Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Arruda, US

Aaron Arruda, San Francisco, CA US

Patent application numberDescriptionPublished
20110083122METHOD AND SYSTEM FOR MASSIVE LARGE SCALE TEST INFRASTRUCTURE - An automated system is provided to support massive scale grid of machines in a rapid, multi-developer coding environment. The system has virtual testing environments that are created from template machines, supporting various software versions for various code branches. The grid is built by having a small subset of template machines (e.g. with Oracle 9g, 10g, and application server installations), images of the template machines, virtual machine instances created by applying one or more of the image templates, which then are used by the virtual testing environment. Upon receipt of code changes, changes are checked-out, compiled, tested on various test feeds on a virtual testing environment, which is destroyed and re-created after every test run. Any software version upgrades or bug fixes need to be applied only to the template machines. The number of virtual machines associated with any particular template machine is dynamically configurable to provision for optimal use of testing machines.04-07-2011

Anthony C. Arruda, Ann Arbor, MI US

Patent application numberDescriptionPublished
20090301071LOW RESTRICTION HYDROCARBON TRAP ASSEMBLY - A hydrocarbon adsorption assembly for an air induction system is disclosed. The hydrocarbon adsorption assembly includes a fluid conduit having an outer surface and a spaced apart inner surface to form a fluid path therein, the conduit including a recessed area formed in the inner surface thereof. A hydrocarbon trap is disposed in the recessed area of the fluid conduit to adsorb hydrocarbons passing through the conduit. The recessed area and the hydrocarbon trap cooperate to cause a portion of an air flowing through the flow path of the conduit to flow through the hydrocarbon trap to facilitate a purging thereof.12-10-2009

Patent applications by Anthony C. Arruda, Ann Arbor, MI US

Anthony Charles Arruda, Ann Arbor, MI US

Patent application numberDescriptionPublished
20090007876AIR INDUCTION SYSTEM WITH RESONATOR BYPASS VALVE - An air induction system for a vehicle is disclosed, wherein the air induction system includes a resonator bypass valve for control of an air flow to an engine and engine induction noise levels emitted therefrom.01-08-2009
20090057054SOUND GENERATOR WITH STRUCTURALLY AND ACOUSTICALLY COUPLED SOUND RADIATION PANEL AND METHOD FOR MANUFACTURING THE SAME - A sound generator for a vehicle is provided, including a hollow drum having a sound radiation panel structurally and acoustically coupled thereto. The drum has an aperture formed in an outer wall thereof. The drum is adapted to be in fluid communication with an air conduit of the vehicle. The sound radiation panel covers at least a portion of the aperture and is adapted to radiate sound energy to at least one of an engine compartment and an interior of the vehicle. A vehicle system including the sound generator and a method for manufacturing the sound generator are also provided.03-05-2009

Edward Mark Arruda, Easton, PA US

Patent application numberDescriptionPublished
20110142783[(4E, 4Z)-5-METHOXY-3-METHYL-4-PENTENYL]-BENZENE AND ITS USE IN PERFUME COMPOSITIONS - The present invention is directed to a novel compound, [(4E, 4Z)-5-methoxy-3-methyl-4-pentenyl]-benzene, and a method of improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of this novel compound.06-16-2011

Edward Mark Arruda US

Patent application numberDescriptionPublished
20080214431SUBSTITUTED 1-(2-ETHYL-1-METHYL-CYCLOPROPYL)-ONE /OL DERIVATIVES - The present invention is directed to novel ketone and alcohol compounds and the use of these novel compounds in creating fragrances, and scents in items such as perfumes, colognes and personal care products.09-04-2008
20080242586ORGANOLEPTIC COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS - The present invention is directed to the novel compounds of the general formula10-02-2008

Patent applications by Edward Mark Arruda US

Edward Mark Arruda, Cliffwood, NJ US

Patent application numberDescriptionPublished
20090062405CYCLOPROPANECARBOXALDEHYDES AND THEIR USE IN PERFUME COMPOSITIONS - The present invention is directed to novel cyclopropanecarboxaldehyde compounds of the general formula03-05-2009
20090068137ORGANOLEPTIC COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS - The present invention is directed to novel compounds which possess unique organoleptic properties containing the following general formula:03-12-2009
20090076313SUBSTITUTED 1-(2-ETHYL-1-METHYL-CYCLOPROPYL)-ONE/OL DERIVATIVES - The present invention is directed to novel ketone and alcohol compounds and the use of these novel compounds in creating fragrances and scents in items such as perfumes, colognes and personal care products.03-19-2009
20090081150CYCLOPROPANATED MACROCYCLIC KETONES AND LACTONES - The present invention is directed to novel cyclopropanated macrocyclic ketone and lactone compounds of the general formula:03-26-2009
20090087402Cyclopropanated Macrocyclic Ketones and Lactones - The present invention is directed to novel cyclopropanated macrocyclic ketone and lactone compounds of the general formula:04-02-2009

Patent applications by Edward Mark Arruda, Cliffwood, NJ US

Ellen M. Arruda, Ann Arbor, MI US

Patent application numberDescriptionPublished
20080199953SYSTEM AND METHOD FOR FORMING A CONNECTIVE TISSUE CONSTRUCT - A system and method are provided for forming a connective tissue construct, such as a tendon construct, in vitro. A substrate is provided with at least two anchors secured thereto in spaced relationship. Fibroblast cells are provided on the substrate in the absence of a synthetic matrix, where at least some of the cells are in contact with the anchors. The cells are cultured in vitro under conditions to allow the cells to self-organize and become confluent between the anchors, where the anchors are receptive to the cells and allow the cells to attach thereto while permitting the cells to detach from the substrate to form a three-dimensional connective tissue construct.08-21-2008
20080241209System and Method for Forming Bone, Ligament, and Bone-Ligament Constructs - A system and method for forming a bone construct include providing bone marrow stromal cells on a substrate without disposing the cells within an exogenous scaffold, and culturing the cells in vitro in osteogenic media such that the cells form a confluent monolayer and detach from the substrate to form a self-organized three-dimensional bone construct. A system and method for forming a ligament construct using fibrogenic media and a system and method for forming a functionally integrated bone-ligament construct are also provided.10-02-2008

Jeannie M. Arruda, Lajolla, CA US

Patent application numberDescriptionPublished
20090203903Thiazolyl mglur5 antagonists and methods for their use - The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.08-13-2009

Jeannie M. Arruda, La Jolla, CA US

Patent application numberDescriptionPublished
201101183155-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.05-19-2011

Valder R. Arruda, Philadelphia, PA US

Patent application numberDescriptionPublished
20090318344COMPOSITIONS AND METHODS FOR MODULATING HEMOSTASIS USING VARIANT FORMS OF ACTIVATED FACTOR V - Methods for the treatment of coagulation disorders using Factor V/Va variants are provided.12-24-2009